GUÍA CLÍNICA DE LA PATOLOGÍA CERVICAL - IVO Instituto ...

BIBLIOGRAFIA
1
Anderson GH, Benet JL, Le Riche JC et al. Invasive cancer of the cervix in British Columbia: a review of the
demography and screening histories of 437 cases seen from 1985-1988. Obstet Gynecol 1992; 80:1-4).
2
Gustafsson L, Pontén J, Bergströn R , Adaami HO. International incidence rates of invasive cervical cancer before
cytological screening. Int J Cancer 1997; 71: 159-165
3
Anderson GH, Benet JL, Le Riche JC et al. Invasive cancer of the cervix in British Columbia: a review of the
demography and screening histories of 437 cases seen from 1985-1988. Obstet Gynecol 1992; 80:1-4).
4
Bosch FX, de Sanjosé S, Prats L, Quintana,MJ. Epidemiología y factores etiológicos del cáncercérvico-uterino. Ginedips
1998;1(1): 51-7.
5
González JR, Moreno V, Borràs JM, SolerM, Kogevinas M, Peris M, et al. Estimación delcáncer en España en el período
1993-1996. XVIII Reunión Ciéntifica de la Sociedad Española de Epidemiología. 25-27 de octubre Madrid, 2000
6
Parkin DM, Whelan SL, Ferlay J. Cancer Incidence in Five Continents. Vol VIII IARC Scientific Publication Nº 36. Lyon:
IARC; 2000
7
Lopez-Abente G et al. Tendencias de la mortalidad en España, 1952-1996. Efecto dela edad, la cohorte de nacimiento
y del periodo de muerte. Madrid: instituto de Carlos III; 2002
8
Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer
worldwide. J Pathol 1999; 189: 12-19
9
Clifford GM, Smith JS, Plumier M, Muñoz N, Francechi S. Human papilomavirus types in invasive cervical cancer
worldwide: a meta-analysis. Br J Cancer. 2003; 88(1): 63-73
10
Clifford GM, Rana RK, Francechi S, Smith JS, Gough G, Pimenta JM. Human papilomavirus genotype distribution in
low-grade cervical lesions: comparation by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers
Prev. 2005; 14(5): 1157-64
11
Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, Shah KV. The casual relation between human papillomavirus and cervical
cancer. J Clin Pathol. 2002; (31): 3-13
12
Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K.Papanicolau test screening and prevalence of genital human
papillomavirus among womwn who have sex with women. Am J Public Health. 2001; 91. 947-52
13
Castellsague X, Bosch FX, Muñoz N, Meijer CJ, Shah KV, De Sanjose S et al, por el IARC Multicenter Cervical Cancer
Study Group. Male circuncisión, penile human papilomavirus infection, and cervical cancer in female partners. N Engl J
Med 2002; 346:1105-12
14
Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamonwicz M, Ferenczy A, et al. The hatural history of type-specific
human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev. 2003; 12: 485-90
15
Muñoz N, Castellsagué X, de Gonzalez AB, Gissmann L. Chapter 1: VPH in the etiology of human cancer.Vaccine.
2006 Aug 21;24S3:S1-S10. Epub 2006 Jun 23
16
Cortes J. Estrategias de cribado de cáncer de cuello uterino. Prog Obstet Ginecol. 2005; 48 Supl 1: 228-30
17
US Preventive Services Task Force (USPSTF). Screening for cervical cancer. http://www.ahrq.gov/clinic/uspstf/
uspscerv.htm.
18
Molden T, Nygard JF, Kraus I, et al. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPVprooferand
consensus PCR : a 2-year follow-up of women with ASCUS or LSIL pap smear. Int J Cancer. 2005;114:973-
6
19
Ho GY, Bierman R, Beardsley I et al. Natural history of cervicovaginal papillomavirus infection in young
wome;338:423-8n. N Engl J Med 1998
20
Soller KL. Cervical citology screening and evaluation. Obstet Gynecol. 2005;106:391-7
21
Europen guidelines for quality assurance in cervical screening. 2003. www.cancernetwork.de/cervical/cerv_guidelines.htm
22
Torrejon R. Factores de riesgo de cancer uterino. Estrategias de prevención. Salud Total de la Mujer. 2002; 4;23-31
23
IARC. Handbooks of cancer prevention. Cervix cancer screening. Lyon : IARC Press; 2005
24
Feng Q, Kiviat NB.New and surprising insights into patogénesis of multicentric squmous cancers in the female lower
genital tract. J Natl Cancer Inst. 2005;97: 1798-9
25
Asociación Española de Patología Cervical y Colposcopia. Manual de colposcopia básica. Pulso
Ediciones SL.Barcelona 2002. Disponible en www.aepcc.org.
26
Dexeus S, Cararach M, Dexeus D. The role of colposcopy in modern ginecology. Eur. J Gynaecol Oncol.2002; 23;269-
277.
27
Kyrgiou M, Tsoumpou I, Vrekoussis T, et al. The up-to- date evidence on colposcopy practice and treatment of
cervical intraepithelial neoplasia: The cochrane colposcopy & cervical cytopathology collaborative group (C5 group)
approach. Cancer Treat Rev. 2006;32:516-523.
28
Walker P, Dexeus S, De Palo G, et al. por el Nomenclature Committee of the IFCPC. International Terminology of
Colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet
Gynecol. 2003;101: 175-177.
29
A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. ASCUS-
LSIL Triage Study (ALTS) Group. Am J Obstet Gynecol 2003; 188: 1393-1400.
30
Kadish AS, Burk RD et al. Human papillomavirus of different types in pre-cancerous lesions of the uterine cervix:
histologic, immunocytochemical and ultra-structural studies. Hum Pathol 1986; 17: 384-392
31
Willett GD, Kurman Rj: Correlation of the histological appearance of intraepithelial neoplasia of the cervix with human
papillomavirus types. Mt J. Gynecol Pathol 1989; 8: 18-25.
32
Wright TC, Ferenzy AF, Kurman Rj. Precancerous lesions of the cervix. En: Kurman Rj. Ed Blaustein’s Pathology of the
Female Genital Tract, 5 th Ed. New York: Springer- Verlag, 2002: 253-354.
33
Solomon D, Davey D, Kurgan R, et al. The 2001 Bethesda System: terminology for reporting results of cervical
cytology. Jama 2002; 287: 2114-2112.
34
Johnson LD, Nickerson RJ. Epidemiologic evidence for spectrum of change from dysplasia through carcinoma in situ
to invasive cancer. Cancer 1968, 22: 901-914.
38